
GLUE
Monte Rosa Therapeutics Inc.
$10.27
+$0.23(+2.24%)
64
Overall
60
Value
100
Tech
34
Quality
Market Cap
$455.78M
Volume
1.46M
52W Range
$3.50 - $12.40
Target Price
$16.20
EPS Estimates Overview
Current Quarter | $-0.39 | Next Quarter | $-0.39 |
Current Year | $-0.3 | Next Year | $-1.08 |
QoQ Growth | +0.0% | YoY Growth | -260.0% |
3Y EPS CAGR | +30.8% | Target Price | $16.20 |
Consensus | Buy | Upside | +57.8% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
Current Quarter Rev | N/A | Next Quarter Rev | N/A |
Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | GLUE | $10.27 | +2.2% | 1.46M |
3 | ||||
4 | ||||
5 | ||||
6 |
Get Monte Rosa Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW